nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiplatelet therapy: Do the new platelet inhibitors add significantly to the clinicl benefits of aspirin?
|
Théroux, Pierre |
|
1997 |
134 |
5P2 |
p. s62-s70 nvt p. |
artikel |
2 |
Introduction
|
Califf, Robert |
|
1997 |
134 |
5P2 |
p. s53-s54 nvt p. |
artikel |
3 |
Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease
|
Califf, Robert M. |
|
1997 |
134 |
5P2 |
p. s88-s96 nvt p. |
artikel |
4 |
Rationale for low–molecular weight heparin in coronary stenting
|
Zidar, James P. |
|
1997 |
134 |
5P2 |
p. s81-s87 nvt p. |
artikel |
5 |
Successors to heparin: New antithrombotic agents
|
Turpie, Alexander G.G. |
|
1997 |
134 |
5P2 |
p. s71-s77 nvt p. |
artikel |
6 |
The evolution of antithrombotic therapy in coronary stenting
|
Schatz, Richard A. |
|
1997 |
134 |
5P2 |
p. s78-s80 nvt p. |
artikel |
7 |
Triggering and the pathophysiology of acute coronary syndromes
|
Tofler, Geoffrey H. |
|
1997 |
134 |
5P2 |
p. s55-s61 nvt p. |
artikel |